Search results
-
Roche Holding AG: Funding the Genentech Acquisition
Schill, Michael J.; Durick, Brett; Chambers, DrewCase DARDEN-F-1645-EFinanceThis case examines the decision by the Swiss pharmaceutical Roche Holding AG (Roche) to offer a record $42 billion bond in February 2009. In light of a pending acquisition of US biotechnology leader Genentech, Roche management planned to sell $32 billion in bonds at various maturities from 1 year to 30 years and in three different currencies (US dollar, euro, and British pound). In a context of substantial uncertainty in both world financial mark...Starting at €8.20